18 East 50th Street, 5th Floor
47 articles with Axim Biotech
Medical Marijuana, Inc. Major Investment Company AXIM® Biotechnologies Begins GMP Manufacturing Of Cannabinoid-Based Gum With Dronabinol For Use In Upcoming Clinical Studies
Medical Marijuana, Inc. (OTC: MJNA) ("the Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its major investment company AXIM® Biotechnologies, Inc. ("AXIM® Biotech" or "AXIM") (OTCQB: AXIM) has begun manufacturing its cannabinoid-based chewing gum with dronabinol, a synthetic form of tetrahydrocannabinol (THC).
Medical Marijuana, Inc. Major Investment Company AXIM® Biotechnologies, Inc. Moves Forward on Oral Healthcare Line With Cannabinoid Product Supply Agreement
The agreement states that AXIM will supply its patented toothpaste and mouthwash containing cannabidiol (CBD) for Impression's clinical trial for the treatment of periodontitis.
Medical Marijuana, Inc. Major Investment Company Axim® Biotechnologies Files New U.S. Provisional Patent for Cannabis Gum as a Treatment for Migraine Symptoms
Medical Marijuana, Inc. announced that the Company's major investment company AXIM® Biotechnologies, Inc., a world leader in cannabinoid research and development, has filed a provisional patent application with the United States Patent and Trademark Office.
AXIM® BIOTECHNOLOGIES EARNS GMP LICENSE FROM DUTCH MINISTRY OF HEALTH TO PRODUCE CANNABINOID-BASED PHARMACEUTICAL PRODUCTS
New License Allows Leading Cannabinoid Biopharmaceutical Company to Advance Production of Clinical Trial Products
The DEA has reclassified GW Pharmaceutical’s cannabidiol epilepsy treatment Epidiolex as a Schedule V product, which will clear the way for commercialization within the next six weeks.
AXIM® Biotechnologies to Present at 28th Annual International Cannabinoid Research Society Symposium in The Netherlands
AXIM® Biotechnologies, Inc. announced that the company will be attending as a sponsor at the 28th Annual International Cannabinoid Research Society (ICRS) Symposium
6/26/2018In a first of its kind ruling, the U.S. Food and Drug Administration approved GW Pharmaceuticals’ Epidiolex, a cannabis-based treatment for seizures associated with two rare forms of epilepsy, Lennox-Gastaut syndrome (LGS) and Dravet syndrome.
AXIM Biotech Announces Successful Completion of Exploratory Meeting with the Dutch Medicines Evaluation Board on MedChew Rx Program for Treatment of Pain and Spasticity in MS Patients
In the meeting, the Company and the Dutch authorities discussed the overall development plan for MedChew Rx in the country and across Europe.
AXIM Biotech Announces Successful Completion of Pre-IND Meeting With FDA on Comparable Product to Marinol; Green Light From FDA for IND Submission
AXIM will now begin preparing its IND filing to the FDA for this new chewing gum product.
As of September 30, 2017, cash was $3.1 million, compared to $0.7 million as of December 31, 2016.
Axim Biotechnologies Announces Phase IIa Trial Results Validating its Proprietary Cannabinoid Delivery Method for Treatment of Irritable Bowel Syndrome (IBS)
Participants of AXIM Biotech’s Phase IIa trial experienced a decrease in their pain score and improvement in their quality of life score, highlighting the efficacy of AXIM’s patented CBD chewing gum delivery method, allowing for AXIM to move forward with further trials with predetermined dosing.
New U.S. Patent Allowance Granted To Axim Biotech For Cannabinoid Ophthalmic Solutions For Glaucoma And Conjunctivitis Treatment
Axim Biotech Enters Clinical Study Agreement With University of British Columbia To Begin Clinical Trial On CBD Chewing Gum For Treatment Of Drug-Related Psychosis
Medical Marijuana, Inc. Major Investment Axim Biotech Enters Agreement With Israel-Based CRO To Begin Clinical POC Study For Treatment Of Restless Leg Syndrome
Axim Biotech Enters Services Agreement With Israel-Based CRO To Begin Clinical POC Study On CBD And Gabapentin Chewing Gum For Treatment Of Restless Leg Syndrome